Search

everythinglearnresearchcommunity

for

Search:↓

A new accurate and reliable method was developed to measure Spironolactone and Hydrochlorothiazide together in medicines.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

A new genetic area linked to a rare hair loss condition was found on chromosome 13 in a Chinese family.

Finasteride reduces hair growth and is safe for women with excessive hair.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Routine genetic testing is crucial for early diagnosis and better management of Turner’s syndrome with 21-hydroxylase deficiency.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A boy and his father with hereditary hypotrichosis simplex were treated for hair loss, but the treatment result is unknown.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Indinavir can cause hair loss and other skin problems.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Finasteride effectively treats hidradenitis suppurativa for most patients.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Blocking CXCR4 may help treat hidradenitis suppurativa.